Iron Mountain Incorporated (IRM) grew with the stock adding 1.08% or $0.39 to close at $36.59 on light trading volume of 1.25M compared its three months average trading volume of 1.55M. The Boston Massachusetts 02110 based company operating under the Business Software & Services industry has been trending up for the last 52 weeks, with the shares price now 41.8% up for the period and up by 12.65% so far this year. With price target of $40.8 and a 48.7% rebound from 52-week low, Iron Mountain Incorporated has plenty of upside potential, making it a hold with a view buy.
Iron Mountain Incorporated, together with its subsidiaries, provides storage and information management services in North America, Europe, Latin America, and the Asia Pacific. It operates through North American Records and Information Management Business, North American Data Management Business, Western European Business, and Other International Business segments. The company provides storage and information management services for physical records and other media, such as microfilm and microfiche, master audio and videotapes, film, X-rays, and blueprints, including healthcare information services, vital records services, and service and courier operations, as well as the collection, handling, disposal of sensitive documents for corporate customers. It also offers information destruction services primarily consist of physical secure shredding operations; document management solutions to develop, implement, and support storage and information management solutions for the complete lifecycle of its customers’ information; fulfillment services; technology escrow services that protect and manage source code; and professional consulting services, as well as sells resultant waste paper to third-party recyclers. In addition, the company is involved in the storage and rotation of backup computer media operations, including records management, data protection and recovery, server and computer backup services, and digital content repository systems to house, distribute, and archive key media assets, as well as for storage, safeguarding, and electronic or physical delivery of physical media primarily for the entertainment and media industry clients. It serves commercial, legal, banking, healthcare, accounting, insurance, entertainment, and government organizations. Iron Mountain Incorporated was founded in 1951 and is headquartered in Boston, Massachusetts.
Trinity Industries, Inc. (TRN) gained $0.67 to close the day at a new closing price of $28.25, a 2.43% increase in value from its previous closing price that moved the stock 92.84% above its 52 week low of $14.94. A total of 1.25M shares exchanged hands during the day compared with its three month average trading volume of 1.67M. The stock, which fluctuated between $27.51 and $28.33 during the day, currently situated -3.91% below its 52 week high. The stock is down by -0.31% in the past one month and up by 34.99% over the past three months. With a one year target estimate of $24.63 and RSI of 51.73, the stock still has upside potential, making it a hold for now.
Trinity Industries, Inc. provides various products and services for the energy, transportation, chemical, and construction sectors in the United States and internationally. Its Rail Group segment offers railcars, including autorack, box, covered hopper, gondola, intermodal, tank, and open hopper cars; and couplers, axles, and other equipment, as well as railcar maintenance services. This segment serves railroads, leasing companies, and industrial shippers of various products. The company’s Railcar Leasing and Management Services Group segment leases tank and freight railcars to industrial shippers and railroads; and provides management, maintenance, and administrative services. As of December 31, 2015, this segment had a fleet of 76,765 owned or leased railcars. Its Construction Products Group segment offers highway products, such as guardrail, crash cushions, and other protective barriers; aggregates, including expanded shale and clay, crushed stone, sand and gravel, asphalt rock, and other products, as well as other steel products for infrastructure-related projects; and trench shields and shoring products for the construction industry. This segment offers aggregates to concrete producers; commercial, residential, and highway contractors; manufacturers of masonry products; and state and local municipalities. The company’s Energy Equipment Group segment manufactures structural wind towers; utility steel structures for electricity transmission and distribution; storage and distribution containers; cryogenic tanks; and tank heads for pressure and non-pressure vessels. Its Inland Barge Group segment provides deck barges, and open or covered hopper barges to transport grain, coal, and aggregates; and tank barges to transport chemicals and various petroleum products, as well as fiberglass reinforced lift covers for grain barges. Trinity Industries, Inc. was founded in 1933 and is headquartered in Dallas, Texas.
PharmAthene, Inc. (PIP) shares were up in last trading by 4.76% to $3.3. It experienced higher than average volume on day. The stock increased in value by almost 3.13% over the past week and fell 0% in the past month. It is currently trading 2.23% above its 50 day moving average and 21.04% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -5.71% decrease in value from its one year high of $3.5. The RSI indicator value of 54.09, lead us to believe that it is a hold for now.
PharmAthene, Inc., a biodefense company, develops and commercializes medical counter measures against biological and chemical threats in the United States. The company focuses on developing lyophilized anthrax vaccines based on DepoVax, a proprietary technology platform that contributes recombinant protective antigen bulk drug substance. It serves National Institute of Allergy and Infectious Diseases, and the Biomedical Advanced Research and Development Authority. The company has a license agreement with ImmunoVaccine Technologies for the use of the DepoVax vaccine platform to develop an anthrax vaccine. PharmAthene, Inc. is headquartered in Annapolis, Maryland.